Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG: 0874)

Guangzhou Baiyunshan Pharmaceutical Holdings Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16,225	21,309	22,500	22,377	19,470	18,470
Short-Term Investments	254.95	729.16	2,117	-	50	41.5
Trading Asset Securities	4	4	56.87	-	4	-
Cash & Short-Term Investments	16,484	22,042	24,673	22,377	19,524	18,511
Cash Growth	-25.70%	-10.67%	10.26%	14.61%	5.47%	4.84%
Accounts Receivable	21,339	19,598	19,168	17,211	15,689	15,597
Other Receivables	1,059	882.35	920.51	1,276	765.71	1,173
Receivables	22,398	20,480	20,088	18,486	16,455	16,770
Inventory	10,751	11,507	10,672	10,438	9,765	9,490
Other Current Assets	2,307	1,955	1,631	1,510	1,653	1,211
Total Current Assets	51,940	55,984	57,064	52,811	47,397	45,982
Property, Plant & Equipment	7,793	7,516	6,570	5,684	5,101	4,437
Long-Term Investments	12,437	9,452	5,897	2,891	2,751	1,943
Goodwill	830.85	829.47	829.47	829.47	825.57	825.57
Other Intangible Assets	2,856	2,886	2,585	2,582	2,444	2,485
Long-Term Deferred Tax Assets	1,219	1,164	865.34	794.23	751.72	594.99
Long-Term Deferred Charges	351.78	499.77	407.47	143.05	118.04	117.8
Other Long-Term Assets	542.13	256.22	446.54	382.46	372.43	507.73
Total Assets	77,971	78,587	74,665	66,118	59,760	56,894
Accounts Payable	15,289	15,686	14,961	14,733	14,159	13,681
Accrued Expenses	1,039	3,651	3,484	3,478	2,888	2,883
Short-Term Debt	9,242	7,799	9,146	8,428	8,266	5,869
Current Portion of Long-Term Debt	-	36.45	498.58	30.03	-	15.5
Current Portion of Leases	849.64	213.38	208.15	215.77	236.11	213.86
Current Income Taxes Payable	443.41	249.26	237	143.41	238.38	170.52
Current Unearned Revenue	1,450	5,430	5,644	2,740	1,249	4,675
Other Current Liabilities	5,939	3,170	3,216	2,485	2,207	1,868
Total Current Liabilities	34,251	36,235	37,395	32,254	29,243	29,377
Long-Term Debt	3,255	3,324	1,639	752.81	497.55	4.5
Long-Term Leases	538.16	578.19	545.84	497.7	561.82	546.99
Long-Term Unearned Revenue	1,021	1,001	930.93	826.86	784.07	575.84
Long-Term Deferred Tax Liabilities	655.99	639.53	394.59	331.73	286.36	266.91
Other Long-Term Liabilities	133.24	130.6	121.45	127.87	181.45	132.64
Total Liabilities	39,855	41,909	41,027	34,791	31,555	30,904
Common Stock	1,626	1,626	1,626	1,626	1,626	1,626
Additional Paid-In Capital	10,114	10,106	10,106	9,957	9,885	9,865
Retained Earnings	24,543	23,212	20,347	17,497	14,652	12,694
Comprensive Income & Other	-19.37	-24.34	-12.9	-17.48	-17.67	-0.14
Total Common Equity	36,263	34,919	32,065	29,062	26,145	24,185
Minority Interest	1,852	1,759	1,573	2,264	2,060	1,805
Shareholders' Equity	38,116	36,678	33,638	31,327	28,205	25,989
Total Liabilities & Equity	77,971	78,587	74,665	66,118	59,760	56,894
Total Debt	13,885	11,951	12,038	9,924	9,561	6,650
Net Cash (Debt)	2,599	10,091	12,635	12,453	9,963	11,861
Net Cash Growth	-71.01%	-20.13%	1.47%	24.99%	-16.00%	4.62%
Net Cash Per Share	1.60	6.21	7.77	7.66	6.13	7.30
Filing Date Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Total Common Shares Outstanding	1,626	1,626	1,626	1,626	1,626	1,626
Working Capital	17,689	19,748	19,669	20,557	18,153	16,605
Book Value Per Share	22.31	21.48	19.72	17.88	16.08	14.88
Tangible Book Value	32,576	31,203	28,651	25,650	22,876	20,874
Tangible Book Value Per Share	20.04	19.19	17.62	15.78	14.07	12.84
Buildings	-	4,328	3,630	3,317	3,105	3,049
Machinery	-	4,416	4,025	3,582	3,103	2,963
Construction In Progress	-	2,405	2,108	1,564	1,276	667.4

Source: S&P Capital IQ. Standard template. Financial Sources.